Is preoperative weight reduction of living-donor liver transplant recipients and donors harmful to postoperative outcomes?

被引:0
作者
Yoshiya, Shohei [1 ]
Itoh, Shinji [1 ]
Toshima, Takeo [1 ]
Izumi, Takuma [1 ]
Iseda, Norifumi [1 ]
Tsutsui, Yuriko [1 ]
Toshida, Katsuya [1 ]
Nakayama, Yuki [1 ]
Ishikawa, Takuma [1 ]
Tanaka, Yasushi [1 ,2 ]
Ninomiya, Mizuki [1 ]
Yoshizumi, Tomoharu [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka, Japan
关键词
Donor weight reduction; Living -donor liver transplantation; Postoperative outcomes; Preoperative weight reduction; Recipient weight reduction; BODY-MASS INDEX; HEPATIC STEATOSIS; FATTY LIVER; OVERWEIGHT; SAFETY;
D O I
10.1016/j.gassur.2024.04.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose: Although the incidence of recipients and donors with overweight and obesity is increasing worldwide, few reports have focused on outcomes of preoperative weight reduction (WR) in living-donor liver transplantation (LDLT). Therefore, we examined the outcomes and the impact of WR on the postoperative course. Methods: We analyzed 217 consecutive LDLT procedures performed from 2017 to 2022. We divided the recipients and donors into a WR group and non-WR group. Results: Twenty-two recipients (10.1%) achieved WR (preoperative recipient WR [RWR] group), reducing their weight by 6.8% +/- 6.0% within 2.2 +/- 1.4 months with a significant decrease in body mass index (BMI) (P < .0001). The RWR group showed no significant differences in short-term postoperative outcomes (operative factors, postoperative liver function tests, amount of ascites, and morbidity) or in the graft survival rate as a long-term outcome (P = .24) compared with the non-RWR group. Forty-one donors (18.9%) achieved WR (preoperative donor WR [DWR] group), reducing their weight by 9.7% +/- 6.3% within 3.2 +/- 5.8 months with a significant decrease in BMI (P < .0001). Compared with the non-DWR group, the DWR group showed no significant differences in short-term postoperative outcomes between themselves and recipients or in the graft survival rate (P = .49). Furthermore, WR resulted in an increase to 32 donor-eligible and 6 recipient-eligible patients. Conclusion: WR in LDLT recipients and donors had no harmful effect on postoperative outcomes and should lead to increase recipients' chance of undergoing LDLT and to expand the donor pool. (c) 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1033 / 1038
页数:6
相关论文
共 50 条
  • [41] Expression of alpha smooth muscle actin in living donor liver transplant recipients
    Masataka Hirabaru
    Kyoko Mochizuki
    Mitsuhisa Takatsuki
    Akihiko Soyama
    Taiichiro Kosaka
    Tamotsu Kuroki
    Isao Shimokawa
    Susmu Eguchi
    World Journal of Gastroenterology, 2014, (22) : 7067 - 7074
  • [42] Expression of alpha smooth muscle actin in living donor liver transplant recipients
    Hirabaru, Masataka
    Mochizuki, Kyoko
    Takatsuki, Mitsuhisa
    Soyama, Akihiko
    Kosaka, Taiichiro
    Kuroki, Tamotsu
    Shimokawa, Isao
    Eguchi, Susumu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (22) : 7067 - 7074
  • [43] The Causes, Risk Factors, and Outcomes of Early Relaparotomy After Living-Donor Liver Transplantation
    Yoshiya, Shohei
    Shirabe, Ken
    Kimura, Koichi
    Yoshizumi, Tomoharu
    Ikegami, Toru
    Kayashima, Hiroto
    Toshima, Takeo
    Uchiyama, Hideaki
    Soejima, Yuji
    Maehara, Yoshihiko
    TRANSPLANTATION, 2012, 94 (09) : 947 - 952
  • [44] Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt
    Saleh, Ahmed Mohamed
    Hassan, Essam Ali
    Gomaa, Ahmed Ali
    El Baz, Tamer Mahmoud
    El-Abgeegy, Mohamed
    Seleem, Mohamed Ismail
    Abo-amer, Yousry Esam-Eldin
    Elsergany, Heba Fadl
    Mahmoud, Eman Ibrahim El-Desoki
    Abd-Elsalam, Sherief
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 2277 - 2282
  • [45] Prognostic Significance of Preoperative Imaging in Recipients of Living Donor Liver Transplantation for Hepatocellular Carcinoma
    Sugimachi, Keishi
    Shirabe, Ken
    Taketomi, Akinobu
    Soejima, Yuji
    Iguchi, Tomohiro
    Takeishi, Kazuki
    Toshima, Takeo
    Aishima, Shinichi
    Tajima, Tsuyoshi
    Maehara, Yoshihiko
    TRANSPLANTATION, 2011, 91 (05) : 570 - 574
  • [46] A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients
    Woo-Hyoung Kang
    Gi-Won Song
    Sung-Gyu Lee
    Kyung-Suk Suh
    Kwang-Woong Lee
    Nam-Joon Yi
    Jae Won Joh
    Choon Hyuck David Kwon
    Jong Man Kim
    Dong Lak Choi
    Joo Dong Kim
    Myoung Soo Kim
    Journal of Gastrointestinal Surgery, 2020, 24 : 832 - 840
  • [48] A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients
    Kang, Woo-Hyoung
    Song, Gi-Won
    Lee, Sung-Gyu
    Suh, Kyung-Suk
    Lee, Kwang-Woong
    Yi, Nam-Joon
    Joh, Jae Won
    Kwon, Choon Hyuck David
    Kim, Jong Man
    Choi, Dong Lak
    Kim, Joo Dong
    Kim, Myoung Soo
    JOURNAL OF GASTROINTESTINAL SURGERY, 2020, 24 (04) : 832 - 840
  • [49] Safety evaluation of donors for living-donor liver transplantation in Chinese mainland: A single-center report
    Li, Guo-Qiang
    Zhang, Feng
    Li, Xiang-Cheng
    Sun, Bei-Cheng
    Cheng, Feng
    Ge, Wen-Gang
    Wang, Xue-Hao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (32) : 4379 - 4384
  • [50] Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation
    Chung, Jae Hun
    Ryu, Je Ho
    Yang, Kwang Ho
    Choi, Byung Hyun
    Park, Youngmok
    Lee, Tae Beom
    Shim, Jae Ryong
    Ko, Hyo Jung
    Cho, Sung Hwan
    ANNALS OF TRANSPLANTATION, 2020, 25 : 1 - 7